Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$USB, $SRPT, $CISN, $DXCM

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Monday, as follows:

US Bancorp Inc. (NYSE:USB) analysts raised to Buy from Neutral at Citigroup. The 52-wk trading range for the stock is 49.03 – 58.80. The consensus price target is 58.56.

Sarepta Therapeutics Inc. (NASDAQ:SRPT) was raised to Overweight from Equal Weight at Barclays. The 52-wk trading range for the biotech company is 28.82 – 92.98. The consensus price target is posted at 88.47. .

Cision Ltd. (NASDAQ:CISN) was started with an Outperform rating and a 16 price target at BMO Capital Markets. The consensus target is at 19. The 52-wk trading range is 10 – 14.19.

Dexcom Inc. (NASDAQ:DXCM) was started with a Buy rating and a 100 price objective at Merrill Lynch. The consensus target is 82.55. The 52-wk trading range is 42.62 – 88.09.

Have a terrific week

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH